| Patents for C12P 21 - Preparation of peptides or proteins (112,499) |
|---|
| 10/19/2006 | US20060234337 Expression system for actinomycete-origin cytochrome p-450 in escherichia coli |
| 10/19/2006 | US20060234336 Methylotrophic bacterium for the production of recombinant proteins and other products |
| 10/19/2006 | US20060234335 Conjugated thiophene compound, conprising perfluorinated and alkylated sidechains, conductive organic thin film containing the compound, and field-effect type organic transistor employing the thin film |
| 10/19/2006 | US20060234331 Method of selecting escherichia coli strain overexpressing foreign gene escherichia coli mutant thus selected and process for producing enzyme and compound using the same |
| 10/19/2006 | US20060234328 Anthrax lethal factor is a MAPK kinase protease |
| 10/19/2006 | US20060234320 Pyroglutamyl peptidase and its gene |
| 10/19/2006 | US20060234311 Isolating cells expressing secreted proteins |
| 10/19/2006 | US20060234307 Fusion proteins of of Fc domains with Ang-2 binding peptides; increases biological half life; angiopoietin-2 (Ang-2) |
| 10/19/2006 | US20060234305 Gene encoding G-protein coupled receptor and gene product thereof |
| 10/19/2006 | US20060234297 Screening method |
| 10/19/2006 | US20060234296 Method for generating high affinity antibodies |
| 10/19/2006 | US20060234295 Sandwich immunoassay for identifying partial proanp peptides |
| 10/19/2006 | US20060234291 Site selective acylation |
| 10/19/2006 | US20060234289 Sp110, a polypeptide component of the nuclear body |
| 10/19/2006 | US20060234288 Nucleic acid encoding proteins involved in protein degradation, products and methods related thereto |
| 10/19/2006 | US20060234285 For treating or preventing inflammatory diseases, autoimmune diseases, graft versus host disease (GVHD), allergis, asthma, and/or hepatitis; drug screening |
| 10/19/2006 | US20060234280 Enyzmes having alpha amylase activity and methods of making and using them |
| 10/19/2006 | US20060234260 Chlamydia trachomatis genomic sequence and polypeptides, fragments thereof and uses thereof, in particular for the diagnosis, prevention and treatment of infection |
| 10/19/2006 | US20060234257 NOVX nucleic acids and their encoded polypeptides; diagnostic and therapeutic applications in the detection of a variety of diseases with differential expression in normal vs. diseased tissues, e.g., detection of a variety of cancers. |
| 10/19/2006 | US20060234255 Novel proteins and nucleic acids encoding same |
| 10/19/2006 | US20060234246 diagnosing cancer; drug screening; inhibiting growth of a tumor cell by modulating expression of a gene product |
| 10/19/2006 | US20060234233 Random transposon insertion in staphylococcus aureus and use thereof to identify essential genes |
| 10/19/2006 | US20060234232 Novel n-acetylgalactosamine transferases and nucleic acids encoding the same |
| 10/19/2006 | US20060234222 Soluble recombinant protein production |
| 10/19/2006 | US20060234220 Novel n-acetylglucosamine transferase, nucleic acid encoding the same, antibody against the same and use thereof for diagnosing cancer or tumor |
| 10/19/2006 | US20060234218 P450 proteins |
| 10/19/2006 | US20060234217 Nucleic acid encodes a heat labile alkaline phosphatase, or the complementary sequence |
| 10/19/2006 | US20060234214 Methods of detecting hepatitis C virus |
| 10/19/2006 | US20060233835 Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector |
| 10/19/2006 | US20060233827 85kDa neisserial antigen |
| 10/19/2006 | US20060233826 Nucleotide sequences coding chlamydial membrane protein for use in generating neutralizing antibody which prevents micoorganismal infection |
| 10/19/2006 | US20060233823 Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof |
| 10/19/2006 | US20060233822 Hepatitis e virus monoclonal antibodies or the binding fragments of it and the use thereof |
| 10/19/2006 | US20060233818 Organic compounds |
| 10/19/2006 | US20060233813 Antiviral bifunctional molecules, methods of construction and methods of treating virus-induced cancer therewith |
| 10/19/2006 | US20060233808 Peptabody for cancer treatment |
| 10/19/2006 | US20060233803 treating an inflammatory disorder characterized by elevated expression of the polypeptide of SEQ ID NO: 32 in human, comprising administering an immunoadhesin comprising an extracellular domain sequence of the polypeptide; rheumatoid arthritis, pneumonia, chronic asthma, chronic hepatitis, osteoarthritis |
| 10/19/2006 | US20060233802 Tumour necrosis factor binding ligands |
| 10/19/2006 | US20060233801 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 10/19/2006 | US20060233800 Biological products |
| 10/19/2006 | US20060233792 novel tumor necrosis factor receptor (TRAIN-R) for treating inflammatory bowel disease and arthritic condition; antiinflammatory agents |
| 10/19/2006 | US20060233787 Human cd3-specific antibody with immunosuppressive properties |
| 10/19/2006 | US20060233785 Immunointeractive molecules and uses thereof |
| 10/19/2006 | US20060233782 Polypeptide; a deletion mutant of chondroitinase ABC Type I truncated by a deletion; retains its proteoglycan degrading activity; neurological functional recovery after central nervous system injury or disease |
| 10/19/2006 | US20060233749 Interleukin-19 |
| 10/19/2006 | US20060233747 Polymer-modified synthetic proteins |
| 10/19/2006 | US20060233746 N-terminally chemically modified protein compositions and methods |
| 10/19/2006 | US20060233744 Orthogonal tRNA synthetase that aminoacylates with reduced efficiency; lower km and recognizes selector codon in mRNA |
| 10/19/2006 | US20060233743 Compositions and methods of therapy |
| 10/19/2006 | CA2603779A1 Chimeric proteins comprising yersinia yop, their preparation and pharmaceutical compositions containing them |
| 10/19/2006 | CA2587848A1 Antiinfective lipopeptides |
| 10/19/2006 | CA2583735A1 Orthogonal translation components for the in vivo incorporation of unnatural amino acids |
| 10/18/2006 | EP1712636A1 Method of quickly measuring factor causing early flocculation of yeast |
| 10/18/2006 | EP1712631A2 Fc receptors and polypeptides |
| 10/18/2006 | EP1712565A1 Cell death inducing agents |
| 10/18/2006 | EP1712564A1 Anti-nc1 monoclonal antibody |
| 10/18/2006 | EP1712126A1 Transgenic bird and method of constructing the same |
| 10/18/2006 | EP1711533A2 Methods of producing peptides/proteins in plants and peptides/proteins produced thereby |
| 10/18/2006 | EP1711483A2 A method for manufacturing optically pure coumaryl amino acid salts and the coumaryl amino acid salts thus obtained |
| 10/18/2006 | EP1448595B1 Antimicrobial polypeptides from pseudoplectania nigrella |
| 10/18/2006 | EP1421195B1 SURFACE EXPRESSION VECTORS HAVING pgsBCA, THE GENE CODING POLY-GAMMA-GLUTAMATE SYNTHETASE, AND A METHOD FOR EXPRESSION OF TARGET PROTEIN AT THE SURFACE OF MICROORGANISM USING THE VECTOR |
| 10/18/2006 | EP1358332B1 A serpin in bifidobacteria |
| 10/18/2006 | EP1337636B1 Soluble zcytor 11 cytokine receptors |
| 10/18/2006 | EP1210411B1 Compositions and methods for improved cell culture |
| 10/18/2006 | EP1208196B1 15571, a novel gpcr-like molecule of the secretin-like family and uses thereof |
| 10/18/2006 | EP1165778B1 Uses of casb618 polynucleotides and polypeptides |
| 10/18/2006 | EP1144611B1 Method for recombinant protein production in mammalian cells comprising co-expression with fetuin |
| 10/18/2006 | EP1141286B1 Cytokine receptor chain |
| 10/18/2006 | EP1104479B1 Method for recovering proteins from the interstitial fluid of plant tissues |
| 10/18/2006 | EP1004667B1 Cell cycle-regulating proteins |
| 10/18/2006 | EP0991661B1 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 10/18/2006 | EP0944649B1 METHYLATED, SmD HOMOLOGOUS PEPTIDES, REACTIVE WITH THE ANTIBODIES FROM SERA OF LIVING BEINGS AFFECTED WITH SYSTEMIC LUPUS ERYTHEMATOSUS |
| 10/18/2006 | EP0927252B1 Antibodies against interferon alpha/beta receptor |
| 10/18/2006 | EP0821729B1 Structure-based designed herbicide resistant products |
| 10/18/2006 | EP0797664B1 Use of a human interleukin-11 receptor |
| 10/18/2006 | EP0778849B1 Polyspecific immunoconjugates and antibody composites for targeting the multidrug resistant phenotype |
| 10/18/2006 | CN1849400A Polynucleotides and polypeptides of the erythropoietin gene |
| 10/18/2006 | CN1849397A Insecticidal proteins secreted from bacillus thuringiensis and uses therefor |
| 10/18/2006 | CN1849391A Nitrilases, nucleic acids encoding them and methods for making and using them |
| 10/18/2006 | CN1849389A Methods for producing recombinant proteins |
| 10/18/2006 | CN1849329A CNGH0010 specific polynucleotides, polypeptides, antibodies, compositions, methods and uses |
| 10/18/2006 | CN1847404A Technological process of extracting lactoferritin Lf from human foremilk and its product |
| 10/18/2006 | CN1280309C Erythropoietin with high specific activity |
| 10/18/2006 | CN1279971C Novel method for down-regulation of amyloid |
| 10/17/2006 | USRE39355 Fusion protein with amino acid sequence of mature human insulin-like growth factor; synthesized in recombinant cell culture by host cells transformed with expression vectors; genetic engineering |
| 10/17/2006 | USRE39351 Recombinant construct for expression of Islet Neogenesis Associated Protein; nucleotide sequence linked to transcriptional and translational initiation site; genetic engineering, hybridization, amplification |
| 10/17/2006 | USRE39350 RNA binding protein and binding site useful for expression of recombinant molecules |
| 10/17/2006 | US7122727 Nucleic acid molecules from wheat encoding an R1-protein, and transgenic plant cells and plants comprising the nucleic acid molecules |
| 10/17/2006 | US7122656 MyD88S allows activation of JNK and AP-1, whereas the NF- kappa B pathway is completely blocked; used to obtain immunosuppression (e.g., in the case of transplantation); modulation of the expression of MyD88S can regulate the cellular responses to LPS and other immunological stimuli |
| 10/17/2006 | US7122654 Hybrid; adjust vascular system permeability |
| 10/17/2006 | US7122652 Isolated polynucleotide encoding a variant human pregnane X receptor (hPXR) polypeptide or fragment; detection and genotyping of hPXR alleles in humans, homozygous as well as heterozygous, alleles of the hPXR gene |
| 10/17/2006 | US7122648 Isolated nucleic acids; binding to antibody; diagnosis of muscular disorders |
| 10/17/2006 | US7122641 Methods for purifying protein |
| 10/17/2006 | US7122639 Chemokine alpha-2 antibodies |
| 10/17/2006 | US7122638 Hybridomas cell lines; viricides |
| 10/17/2006 | US7122635 Method and composition for angiogenesis inhibition |
| 10/17/2006 | US7122634 With an immunoreactivity-reducing amino acid of alanine, methionine, leucine; substituting for the naturally-occurring amino acid; correcting hemophilia in a patient deficient in factor VIII or having inhibitors to factor VIII |
| 10/17/2006 | US7122632 Able to down-regulate IL-20; treating inflammatory diseases, psoriasis and inflammatory lung diseases |
| 10/17/2006 | US7122630 Proteins in cell cycle regulation; cell cycle protein binds to SYK kinase |
| 10/17/2006 | US7122629 For forensic analyses, chromosome tissue/cell/organelle-specific markers, production of expression vectors, screening and diagnosis assays |